Developmental Research Program

发展研究计划

• 批准号: 10468968
• 负责人: Marc Ladanyi
• 金额: $ 6.98万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-01 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10468968
• 关键词: Address; Advisory Committees; Animals; Award; Biology; Budgets; Cancer Etiology; Cause of Death; Clinical; Complement; Development; Diagnosis; Funding; Future; Generations; Goals; Growth; Human; Intervention; Investigator-Initiated Research; Knowledge; Lead; Leadership; Learning; Memorial Sloan-Kettering Cancer Center; Natural History; Pathogenesis; Patients; Philanthropic Fund; Process; Prognosis; Research; Research Personnel; Research Project Grants; Resources; Seeds; Soft tissue sarcoma; Talents; Testing; Translational Research; improved; innovation; preference; programs; recruit; sarcoma

Developmental Research Program ABSTRACT/DESCRIPTION The purpose of the Developmental Research Program of the MSKCC SPORE in Soft Tissue Sarcoma is to support innovative translational research projects in sarcoma. The translational research projects in this program aim to use knowledge of animal and human sarcoma biology to develop and test interventions related to improving diagnosis, prognosis, and treatment of patients with soft tissue sarcoma. This program will allow us to respond quickly to new opportunities in translational research and will help us recruit new scientific talent into our SPORE and, more broadly, into sarcoma-relevant research. The specific aims of the Developmental Research Program are: 1) to provide seed funding for innovative, investigator- initiated research in the biology, pathogenesis, progression, and natural history of sarcoma, 2) to fund research with exceptional potential to advance the translational research goals of the SPORE. We are budgeting $400,000 yearly for this program including $50,000 from the SPORE award itself and $350,000 in MSKCC institutional and philanthropic funds. The priority for funding will be those initiatives considered most creative and of the highest scientific quality. Preference will be given to projects that complement the long-term research goals of the SPORE and advance our translational research objectives. The executive committee can also solicit and fund experimental or clinical initiatives that address an urgent and specific need in the MSKCC SPORE in Soft Tissue Sarcoma program or a unique research opportunity. The internal scientific advisory committee will review applications to determine priorities for use of these funds and will annually select projects for funding. Projects may apply for a second year of funding through the same competitive process, and the projects that appear most promising will be considered for incorporation into the SPORE as Research Projects, either in current or future funding cycles.

发展研究计划 摘要/描述 MSKCC SPORE 软组织发展研究计划的目的 肉瘤将支持肉瘤的创新转化研究项目。翻译的 该计划中的研究项目旨在利用动物和人类肉瘤生物学知识 开发和测试与改善诊断、预后和治疗相关的干预措施 软组织肉瘤患者。该计划将使我们能够快速响应新的 转化研究的机会，并将帮助我们招募新的科学人才 SPORE，更广泛地说，涉及肉瘤相关研究。该计划的具体目标 发展研究计划是： 1）为创新、研究者提供种子资金 发起了肉瘤的生物学、发病机制、进展和自然史研究，2) 资助具有特殊潜力的研究，以推进转化研究目标 孢子。我们每年为该计划预算 400,000 美元，其中 50,000 美元来自 SPORE 奖励本身以及 MSKCC 机构和慈善基金的 350,000 美元。优先级为 资金将用于那些被认为最具创意和最高科学质量的举措。 将优先考虑补充 SPORE 长期研究目标的项目 并推进我们的转化研究目标。执行委员会还可以征求和 资助解决 MSKCC 紧急和特定需求的实验或临床计划 SPORE 软组织肉瘤计划或独特的研究机会。内部科学 咨询委员会将审查申请以确定这些资金的优先使用顺序 每年都会选择资助项目。项目可申请第二年的资助 通过同样的竞争过程，最有前途的项目将是 考虑在当前或未来将其作为研究项目纳入 SPORE 资金周期。